
October 7, 2025: AI in Scientific Writing and New Frontiers in Cardiovascular Care | JACC This Week
About this episode
In the October 7, 2025 issue of JACC, Editor-in-Chief Harlan Krumholz discusses how artificial intelligence can enhance clarity in scientific writing—serving as a tool, not a ghostwriter—while maintaining author accountability. A major study shows that nearly all cardiovascular events occur in people with at least one risk factor, reinforcing the need for early detection and management. Emerging research highlights a percutaneous "debulking" technique that may safely manage infected cardiac device leads, and a revived cholesterol ester transfer protein (CETP) inhibitor showing promising lipid and event outcomes. Additional trials explore the benefits of starting combination therapy earlier in diabetes and kidney disease, and a state-of-the-art review revisits the evolving role of fibrinolysis across thromboembolic conditions.
Get every episode summarized
Each time JACC This Week publishes, we email you a written briefing from the transcript — the topics, who appeared, and any specific claims, with the ad reads skipped.
Email me new episodesFree for 3 shows. No card needed.
Hosts & guests
No transcript yet
This episode has not been transcribed. Request it and it moves to the front of the queue.
More episodes
More from JACC This Week

March 10, 2026: Inside JACC Stats: The State of CV Health in Focus | JACC this W...
JACC This Week

March 3, 2026: Hypertrophic Cardiomyopathy in Focus—MAPLE-HCM Trial, Myosin Inh...
JACC This Week

February 24, 2026: ACHD Guideline in Focus—From Survival to Stewardship | JACC T...
JACC This Week

February 17, 2026: Women's Cardiovascular Health in Focus: From Inclusion to Red...
JACC This Week